Tier 2 — strong

Effects of a Singular Dose of Mangiferin-Quercetin Supplementation on Basketball Performance: A Double-Blind Crossover Study of High-Level Male Players

Dimitrios I Bourdas, Antonios K Travlos, Athanasios Souglis, Georgia Stavropoulou, Emmanouil Zacharakis, Dimitrios C Gofas, Panteleimon Bakirtzoglou
Nutrients 2024 16(1):170

Bibliography

PubMed
PMID 38201999
PubMed Central
PMC10781150
DOI
10.3390/nu16010170
Funding
Reported funding/support: This research received no external funding.
Competing interests
Reported disclosure: The authors declare no conflicts of interest with respect to the research, authorship, and/or publication of this article.

Study snapshot

DesignDouble-blind controlled repeated-exercise study
ModelHuman intervention research
Sample38 male basketball players; 19 per group
InterventionMangiferin 84 mg plus quercetin 140 mg before exercise versus placebo
DurationTwo test weeks; supplement given before the second test
EndpointsExercise performance or recovery

What the study showed, in plain terms

Published in 2024, this source examined exercise and recovery. Design: Double-blind controlled repeated-exercise study. Sample/model: 38 male basketball players; 19 per group. The exposure or intervention was Mangiferin 84 mg plus quercetin 140 mg before exercise versus placebo. Follow-up or treatment period: Two test weeks; supplement given before the second test.

The combination improved average circuit time and perceived exertion. Sprint time, heart rate and muscle soreness did not differ significantly.

Combination product and the study's repeated-test sequence prevent attributing improvement to quercetin alone.

Continue with Quercetin Data Center

For topic-level interpretation, read Quercetin for Exercise: Performance, Recovery and Muscle. This is a related guide; the citation panel separately identifies articles that directly cite this paper.

Key findings

  • The combination improved average circuit time and perceived exertion.
  • Sprint time, heart rate and muscle soreness did not differ significantly.
  • The recorded outcome domains were Exercise performance or recovery.
  • The result applies to the tested exposure: Mangiferin 84 mg plus quercetin 140 mg before exercise versus placebo; Two test weeks; supplement given before the second test.

What this study can and cannot tell us

  • Combination product and the study's repeated-test sequence prevent attributing improvement to quercetin alone.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Source check: accessible full text and indexed metadata. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 2
Quercetin prophylaxis in prevention of acute mountain sickness (AMS): a randomized, double blind, placebo controlled phase-II clinical trials
Sarada S K Sagi et al. · European journal of nutrition · 2026
Tier 2
Effects of Quercetin and Citrulline on Nitric Oxide Metabolites and Antioxidant Biomarkers in Trained Cyclists
Jennifer A Kurtz et al. · Nutrients · 2025
Tier 2
Quercetin ingestion alters motor unit behavior and enhances improvement in muscle strength following resistance training in older adults: a randomized, double-blind, controlled trial
Taichi Nishikawa et al. · European journal of nutrition · 2025

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology